M&T Bank Corp Sells 8,424 Shares of The Cooper Companies, Inc. $COO

M&T Bank Corp cut its position in The Cooper Companies, Inc. (NASDAQ:COO) by 23.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,774 shares of the medical device company’s stock after selling 8,424 shares during the period. M&T Bank Corp’s holdings in Cooper Companies were worth $2,195,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in COO. JANA Partners Management LP bought a new stake in shares of Cooper Companies during the third quarter valued at approximately $166,917,000. Rakuten Investment Management Inc. bought a new position in Cooper Companies in the 3rd quarter worth approximately $11,341,000. Massachusetts Financial Services Co. MA raised its position in Cooper Companies by 96.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock worth $212,519,000 after purchasing an additional 1,525,693 shares during the last quarter. Alecta Tjanstepension Omsesidigt lifted its holdings in Cooper Companies by 15.8% during the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock worth $107,112,000 after buying an additional 213,500 shares in the last quarter. Finally, DAVENPORT & Co LLC boosted its position in Cooper Companies by 1,359.7% in the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after buying an additional 528,346 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on COO. Barclays lifted their target price on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a report on Wednesday, March 4th. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Needham & Company LLC upped their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Finally, Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Stock Performance

Shares of COO opened at $60.00 on Friday. The firm has a market cap of $11.71 billion, a P/E ratio of 29.70, a PEG ratio of 1.58 and a beta of 0.89. The Cooper Companies, Inc. has a twelve month low of $59.68 and a twelve month high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The firm’s 50 day moving average price is $71.18 and its two-hundred day moving average price is $76.08.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.03 by $0.07. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.